A pre-fermented symbiotic matrix based on a cereal suspension containing encapsulated probiotics and prebiotics, the manufacturing process and the corresponding use are disclosed. The invention complements the actual functional food market solving problems inherent to reduced shelf-life of foods due to loss of probiotic viability to values below the minimum limits needed to promote biological activity. The invention also improves the enzymatic process in the preparation of the cereal base and the fermentative process conditions at different levels, namely the ability to control the concentration of sugars in the cereal suspension without adding sugars, increase protein and fiber content, reduce fermentation time to reduce energy consumption during the process and reduce the risk of contamination as well as promote long term microbial stability maintenance. The invention is designed for cases where intolerance and/or allergy to dairy products occur, as wells for the pharmaceutical, cosmetic and food industries, including pet food.

Treating, and compositions for treating, a condition and/or a symptom associated with an effect of at least one element of the opioid system in an animal by administering to the animal (i) a therapeutically effective amount of at least one microorganism and/or of a prebiotic thereof, where the microorganism is capable of modulating an effect of at least one element of the opioid system of the animal and (ii) a therapeutically effective amount of at least one compound capable of modulating an effect of an element of the opioid system of the animal.

The disclosure relates to a method for a non-invasive technique to analyze the fate of probiotics and commensal microbiota from the human upper gastrointestinal tract, namely the ileum. The invention further relates to methods for the enumeration and determination of mechanism of action of probiotics in a non-invasive manner from the end of the small intestine. A composition comprising a probiotic delivered in vivo to healthy individuals with an ileostomy bag is described.

This invention provides isolated and characterized secreted molecules from probiotic bacteria for use in compositions and methods for the treatment and/or prevention of infection by harmful pathogenic bacteria. The isolated secreted molecules can also be used in nutritional or medical food products which provide probiotics to the gastrointestinal tract of a mammal.

This invention provides isolated and characterized secreted molecules from probiotic bacteria for use in compositions and methods for the treatment and/or prevention of infection by harmful pathogenic bacteria. The isolated secreted molecules can also be used in nutritional or medical food products which provide probiotics to the gastrointestinal tract of a mammal.

Provided are therapeutic compositions containing Ecobiotic™ populations for prevention, treatment and reduction of symptoms associated with a dysbiosis of a mammalian subject such as a human.

Probiotic compositions suitable for intravaginal administration to a non-human animal comprising one or more strains of bacteria native to the vagina of the species of animal and a non-aqueous base, probiotic products, kits, and systems comprising the probiotic compositions, and methods of using the probiotic compositions, products, kits, and systems.

Probiotic compositions suitable for intravaginal administration to a non-human animal comprising one or more strains of bacteria native to the vagina of the species of animal and a non-aqueous base, probiotic products, kits, and systems comprising the probiotic compositions, and methods of using the probiotic compositions, products, kits, and systems.

Dental devices are described that include isolated, non-pathogenic, hydrogen peroxide-producing bacterial strains and genetically engineered LDH-deficient bacterial strains, which can be used to whiten teeth and treat periodontal disease.

Dental devices are described that include isolated, non-pathogenic, hydrogen peroxide-producing bacterial strains and genetically engineered LDH-deficient bacterial strains, which can be used to whiten teeth and treat periodontal disease.